Literature DB >> 20622616

Association of shock, coagulopathy, and initial vital signs with massive transfusion in combat casualties.

Claire R Larson1, Christopher E White, Philip C Spinella, John A Jones, John B Holcomb, Lorne H Blackbourne, Charles E Wade.   

Abstract

BACKGROUND: Timely initiation of a massive transfusion (MT) protocol is associated with improved survival and reduced transfusion for patients requiring MT; however, a priori identification of this population is difficult. The objective of this study was to compare the results of an MT prediction model and actual MT incidence in combat casualties.
METHODS: We performed a retrospective review of the Joint Theater Trauma Registry transfusion database for all US service personnel injured in combat during overseas contingency operations who received at least 1 unit of blood. Systolic blood pressure at the time of admission, heart rate, hemoglobin, international normalized ratio, and base deficit were used in a previously developed prediction model for MT.
RESULTS: Casualties (n = 1124) were identified who had received at least 1 unit of blood and had all data points. Of these patients, 420 patients (37%) received an MT. Subjects presenting with any two of four possible variables (heart rate >110, systolic blood pressure <110 mm Hg, base deficit < or = -6, and hemoglobin <11) had a 54% incidence of MT with a model sensitivity of 69%. Patients predicted but not observed to receive an MT had earlier time of death and an increased incidence of head injuries compared with those predicted and observed to receive an MT. Patients not predicted but observed to receive an MT had increased chest, abdominal, and extremity injuries than those neither predicted nor observed to receive an MT.
CONCLUSION: The decision to implement an MT seems to rely heavily on clinical evaluation of severity of abdominal and extremity injury rather than physiologic derangement. Using a model based on the physiologic parameters--a more objective measure--may decrease mortality in combat casualties.

Entities:  

Mesh:

Year:  2010        PMID: 20622616     DOI: 10.1097/TA.0b013e3181e423f4

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  21 in total

Review 1.  Protocols for massive blood transfusion: when and why, and potential complications.

Authors:  E Guerado; A Medina; M I Mata; J M Galvan; M L Bertrand
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-09       Impact factor: 3.693

2.  A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients.

Authors:  Lisa M Brown; Mariah S Call; M Margaret Knudson; Mitchell J Cohen; J B Holcomb; C E Wade; K J Brasel; G Vercruysse; J MacLeod; R P Dutton; J R Hess; J C Duchesne; N E McSwain; P Muskat; J Johannigamn; H M Cryer; A Tillou; J F Pittet; M A De Moya; M A Schreiber; B Tieu; S Brundage; L M Napolitano; M Brunsvold; M Brunsvold; G Beilman; A B Peitzman; M S Zenait; J Sperry; L Alarcon; M A Croce; J P Minei; R Kozar; E A Gonzalez; R M Stewart; S M Cohn; J E Mickalek; E M Bulger; B A Cotton; T C Nunez; R Ivatury; J W Meredith; P Miller; G J Pomper; B Marin
Journal:  J Trauma       Date:  2011-08

3.  External validation of a smartphone app model to predict the need for massive transfusion using five different definitions.

Authors:  E I Hodgman; M W Cripps; M J Mina; E M Bulger; M A Schreiber; K J Brasel; M J Cohen; P Muskat; J G Myers; L H Alarcon; M H Rahbar; J B Holcomb; B A Cotton; E E Fox; D J Del Junco; C E Wade; H A Phelan
Journal:  J Trauma Acute Care Surg       Date:  2018-02       Impact factor: 3.313

4.  Defining when to initiate massive transfusion: a validation study of individual massive transfusion triggers in PROMMTT patients.

Authors:  Rachael A Callcut; Bryan A Cotton; Peter Muskat; Erin E Fox; Charles E Wade; John B Holcomb; Martin A Schreiber; Mohammad H Rahbar; Mitchell J Cohen; M Margaret Knudson; Karen J Brasel; Eileen M Bulger; Deborah J Del Junco; John G Myers; Louis H Alarcon; Bryce R H Robinson
Journal:  J Trauma Acute Care Surg       Date:  2013-01       Impact factor: 3.313

5.  Massive Transfusion: The Revised Assessment of Bleeding and Transfusion (RABT) Score.

Authors:  Bellal Joseph; Muhammad Khan; Michael Truitt; Faisal Jehan; Narong Kulvatunyou; Asad Azim; Arpana Jain; Muhammad Zeeshan; Andrew Tang; Terence O'Keeffe
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

6.  Base deficit as a marker of survival after traumatic injury: consistent across changing patient populations and resuscitation paradigms.

Authors:  Erica I Hodgman; Bryan C Morse; Christopher J Dente; Michael J Mina; Beth H Shaz; Jeffrey M Nicholas; Amy D Wyrzykowski; Jeffrey P Salomone; Grace S Rozycki; David V Feliciano
Journal:  J Trauma Acute Care Surg       Date:  2012-04       Impact factor: 3.313

7.  Predictive Models and Algorithms for the Need of Transfusion Including Massive Transfusion in Severely Injured Patients.

Authors:  Marc Maegele; Thomas Brockamp; Ulrike Nienaber; Christian Probst; Herbert Schoechl; Klaus Görlinger; Philip Spinella
Journal:  Transfus Med Hemother       Date:  2012-03-08       Impact factor: 3.747

8.  A pediatric massive transfusion protocol.

Authors:  Sara J Chidester; Nick Williams; Wei Wang; Jonathan I Groner
Journal:  J Trauma Acute Care Surg       Date:  2012-11       Impact factor: 3.313

9.  The impact of missing trauma data on predicting massive transfusion.

Authors:  Amber W Trickey; Erin E Fox; Deborah J del Junco; Jing Ning; John B Holcomb; Karen J Brasel; Mitchell J Cohen; Martin A Schreiber; Eileen M Bulger; Herb A Phelan; Louis H Alarcon; John G Myers; Peter Muskat; Bryan A Cotton; Charles E Wade; Mohammad H Rahbar
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

10.  The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.

Authors:  John B Holcomb; Deborah J del Junco; Erin E Fox; Charles E Wade; Mitchell J Cohen; Martin A Schreiber; Louis H Alarcon; Yu Bai; Karen J Brasel; Eileen M Bulger; Bryan A Cotton; Nena Matijevic; Peter Muskat; John G Myers; Herb A Phelan; Christopher E White; Jiajie Zhang; Mohammad H Rahbar
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.